Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q3 2024 · 10-Q
Revenue$8.07M$8.07M+2.5% vs Q3 2023 Net Income$1.05M$1.05M+54.5% vs Q3 2023 EPS Diluted$0.13$0.13+62.5% vs Q3 2023 Operating Income$1,389,890+19.7% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$2,251,595N/M Margins · derivedOperating margin17.2%+2.5 pt vs Q3 2023
Net margin13.0%+4.4 pt vs Q3 2023
ended Aug 31, 2024 · filed Oct 15, 2024 · 45 d after period end